287 related articles for article (PubMed ID: 24438336)
21. [Prevention of mother-to-child transmission of toxoplasmosis: perspectives].
Mandelbrot L
Gynecol Obstet Fertil; 2012 Oct; 40(10):591-8. PubMed ID: 22981973
[TBL] [Abstract][Full Text] [Related]
22. Toxoplasmosis in pregnant women in Crete.
Antoniou M; Tzouvali H; Sifakis S; Galanakis E; Georgopoulou E; Tselentis Y
Parassitologia; 2007 Dec; 49(4):231-3. PubMed ID: 18689233
[TBL] [Abstract][Full Text] [Related]
23. Congenital toxoplasmosis: What is the evidence for chemoprophylaxis to prevent fetal infection?
Mandelbrot L
Prenat Diagn; 2020 Dec; 40(13):1693-1702. PubMed ID: 32453454
[TBL] [Abstract][Full Text] [Related]
24. [Toxoplasma infections in early pregnancy: consequences and management].
Wallon M; Gaucherand P; Al Kurdi M; Peyron F
J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):478-84. PubMed ID: 12379832
[TBL] [Abstract][Full Text] [Related]
25. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France.
Gilbert RE; Gras L; Wallon M; Peyron F; Ades AE; Dunn DT
Int J Epidemiol; 2001 Dec; 30(6):1303-8. PubMed ID: 11821334
[TBL] [Abstract][Full Text] [Related]
26. Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women.
Logar J; Petrovec M; Novak-Antolic Z; Premru-Srsen T; Cizman M; Arnez M; Kraut A
Scand J Infect Dis; 2002; 34(3):201-4. PubMed ID: 12030394
[TBL] [Abstract][Full Text] [Related]
27. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment.
Hohlfeld P; Daffos F; Thulliez P; Aufrant C; Couvreur J; MacAleese J; Descombey D; Forestier F
J Pediatr; 1989 Nov; 115(5 Pt 1):765-9. PubMed ID: 2681638
[TBL] [Abstract][Full Text] [Related]
28. [Prevention and treatment of materno-fetal toxoplasmosis].
Fortier B; Ajana F; Pinto de Sousa MI; Aissi E; Camus D
Presse Med; 1991 Sep; 20(29):1374-83. PubMed ID: 1835012
[TBL] [Abstract][Full Text] [Related]
29. Successful tolerance induction to spiramycin in pregnancy.
Nucera E; Roncallo C; Masini L; Buonomo A; De Pasquale T; Pollastrini E; Schiavino D; Patriarca G
Scand J Infect Dis; 2002; 34(7):550-1. PubMed ID: 12195890
[TBL] [Abstract][Full Text] [Related]
30. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years.
Wallon M; Peyron F; Cornu C; Vinault S; Abrahamowicz M; Kopp CB; Binquet C
Clin Infect Dis; 2013 May; 56(9):1223-31. PubMed ID: 23362291
[TBL] [Abstract][Full Text] [Related]
31. [Congenital toxoplasmosis: prevention in the pregnant woman and management of the neonate].
Pelloux H; Fricker-Hidalgo H; Pons JC; Bost-Bru C; Brenier-Pinchart MP; Jouk PS; Ambroise-Thomas P
Arch Pediatr; 2002 Feb; 9(2):206-12. PubMed ID: 11915504
[TBL] [Abstract][Full Text] [Related]
32. Role of spiramycin/cotrimoxazole association in the mother-to-child transmission of toxoplasmosis infection in pregnancy.
Valentini P; Annunziata ML; Angelone DF; Masini L; De Santis M; Testa A; Grillo RL; Speziale D; Ranno O
Eur J Clin Microbiol Infect Dis; 2009 Mar; 28(3):297-300. PubMed ID: 18716804
[TBL] [Abstract][Full Text] [Related]
33. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis.
Daffos F; Forestier F; Capella-Pavlovsky M; Thulliez P; Aufrant C; Valenti D; Cox WL
N Engl J Med; 1988 Feb; 318(5):271-5. PubMed ID: 3336419
[TBL] [Abstract][Full Text] [Related]
34. Allergy to spiramycin during prophylactic treatment of fetal toxoplasmosis.
Ostlere LS; Langtry JA; Staughton RC
BMJ; 1991 Apr; 302(6782):970. PubMed ID: 2032060
[No Abstract] [Full Text] [Related]
35. Congenital toxoplasmosis: late pregnancy infections detected by neonatal screening and maternal serological testing at delivery.
Lago EG; Neto EC; Melamed J; Rucks AP; Presotto C; Coelho JC; Parise C; Vargas PR; Goldbeck AS; Fiori RM
Paediatr Perinat Epidemiol; 2007 Nov; 21(6):525-31. PubMed ID: 17937738
[TBL] [Abstract][Full Text] [Related]
36. Treatment of Acute Toxoplasmosis in Pregnancy: Influence in the Mother-to-Child Transmission.
Bartholo BBGR; Monteiro DLM; Rodrigues NCP; Trajano AJB; de Jesus NR; Cardoso FFO; de Souza FM; Werner H; Araujo Júnior E
J Obstet Gynaecol Can; 2020 Dec; 42(12):1505-1510. PubMed ID: 32912728
[TBL] [Abstract][Full Text] [Related]
37. [Spiramycin (Rovamycin) in the treatment of toxoplasmosis in pregnancy].
Budanov SV
Antibiot Khimioter; 2001; 46(4):38-41. PubMed ID: 11550507
[No Abstract] [Full Text] [Related]
38. What is known about the prevention of congenital toxoplasmosis?
Jeannel D; Costagliola D; Niel G; Hubert B; Danis M
Lancet; 1990 Aug; 336(8711):359-61. PubMed ID: 1975344
[TBL] [Abstract][Full Text] [Related]
39. Role of spiramycin in prevention of fetal toxoplasmosis.
Avci ME; Arslan F; Çiftçi Ş; Ekiz A; Tüten A; Yildirim G; Madazli R
J Matern Fetal Neonatal Med; 2016; 29(13):2073-6. PubMed ID: 26365472
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcome of children with congenital toxoplasmosis.
Berrébi A; Assouline C; Bessières MH; Lathière M; Cassaing S; Minville V; Ayoubi JM
Am J Obstet Gynecol; 2010 Dec; 203(6):552.e1-6. PubMed ID: 20633868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
